New Materials Series B Investors & VC Firms
280 firms in this list, with a median first check of $540K. 13 of them lead rounds. Generated from verified public data and updated continuously.
Silverstrand Capital
Seed–Series B
2 people
TO VC
New YorkSeed–Series B
2 people
Trellis Capital Corporation
TorontoSeries A–Series B
2 people
Urania Ventures
BerlinSeed–Late Stage
2 people
Venture
MadisonSeed–Series B
2 people
Wild Basin Investments
TexasSeed–Series B
2 people
Zeon Ventures
San JoseSeed–Series B
2 people
Mizuho Capital
TokyoSeed–Late Stage
1 person
AddVentures by SCG
BangkokSeed–Late Stage
1 person
Amnis Ventures
HoustonSeed–Series B
1 person
Augere Venture
KrakówSeed–Late Stage
1 person
Daesung Private Equity
SeoulSeries A–Late Stage
1 person
Energy & Environment Investment
TokyoSeed–Late Stage
1 person
Finaventures
Redwood CitySeed–Series B
1 person
Hokkaido Venture Capital, Inc.
SapporoSeed–Late Stage
1 person
ID8 Investments
New YorkSeries A–Series B
1 person
INCJ, Ltd.
TokyoSeed–Growth
1 person
Kolon Investment, Inc.
SeoulSeed–Late Stage
1 person
Mitsui Sumitomo Insurance Capital
TokyoSeed–Late Stage
1 person
New Alliance Capital
ShanghaiSeed–Late Stage
1 person
Raisewell Ventures
BerkeleyPre-Seed–Series B
1 person
Seoul Investment Partners
SeoulSeed–Late Stage
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Shinhan Venture Investment
SeoulSeries A–Growth
1 person
Related lists
Series B Investors & VC Firms (2615)Series B Investors & VC Firms in United States (1005)SaaS Series B Investors & VC Firms (750)Enterprise Software Series B Investors & VC Firms (731)New Materials Investors & VC Firms (652)Healthtech Series B Investors & VC Firms (596)New Materials Series A Investors & VC Firms (590)New Materials Seed Investors & VC Firms (560)Fintech Series B Investors & VC Firms (550)Biotech Series B Investors & VC Firms (526)
Data sourced from public filings and firms' own websites — see our methodology.